To ensure that future leaders will be up to the challenges they will face, pharma companies are pursuing unique programs focused on problem-solving — sometimes sending employees to developing countries where they must tackle real-world problems.
Recent M&A activity in the clinical research space has been dominated by large deals, such as the mergers between Quintiles+IMS Health and INC Research+inVentiv Health. However, 2018 marked a departure from massive consolidation.
The value of China’s biotechs fell some 30 percent since the trade war began, and VC funding, while strong, slipped before that. Interest in China, however, remains strong.
Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director.
Connect With Life Science Leader:
This website uses cookies to ensure you get the best experience on our website. Learn more